Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roser Velasco

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Leukemia & Lymphoma|August 14, 2024
Arsenic trioxide-induced peripheral neuropathy: prospective clinical and neurophysiological evaluation in a cohort of patients with acute promyelocytic leukemiaAlessandro Cellini, Alessandro Salvalaggio, Roser Velasco, et al.
The Lancet. Neurology|December 15, 2023
Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromesAntonio Farina, Macarena Villagrán-García, Alberto Vogrig, et al.
JAMA Neurology|March 15, 2021
Encephalitis Induced by Immune Checkpoint Inhibitors: A Systematic ReviewRoser Velasco, Macarena Villagrán, Maria Jové, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 2019
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settingsAndreas A Argyriou, Susanna B Park, Badrul Islam, et al.
Journal of the Peripheral Nervous System : JPNS|March 14, 2020
Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: Experience beyond the clinical trialsJordi Bruna, Andreas A Argyriou, Garifallia G Anastopoulou, et al.
Journal of the Peripheral Nervous System : JPNS|September 6, 2019
Liability of the voltage-gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin-induced peripheral neurotoxicityAndreas A Argyriou, Anna G Antonacopoulou, Paola Alberti, et al.
Ejhaem|July 18, 2022
Liquid biopsy for disease monitoring after anti-CD19 chimeric antigen receptor T cell in diffuse large B-cell lymphomaClara Maluquer, Beatriz Bellosillo, Alberto Mussetti, et al.
Journal of Clinical Medicine|January 8, 2023
Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case SeriesCarla Marco, Marta Simó, Montse Alemany, et al.
Cancer Chemotherapy and Pharmacology|October 31, 2012
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancerMarta Lucchetta, Sara Lonardi, Francesca Bergamo, et al.
Neurology|May 5, 2026
Sarcopenia in Patients With Cancer and Its Association With Chemotherapy-Induced Peripheral NeurotoxicityRoser Velasco, Sarah Besora, Marta Bellver, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|August 14, 2024
Arsenic trioxide-induced peripheral neuropathy: prospective clinical and neurophysiological evaluation in a cohort of patients with acute promyelocytic leukemiaAlessandro Cellini, Alessandro Salvalaggio, Roser Velasco, et al.
The Lancet. Neurology|December 15, 2023
Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromesAntonio Farina, Macarena Villagrán-García, Alberto Vogrig, et al.
JAMA Neurology|March 15, 2021
Encephalitis Induced by Immune Checkpoint Inhibitors: A Systematic ReviewRoser Velasco, Macarena Villagrán, Maria Jové, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 2019
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settingsAndreas A Argyriou, Susanna B Park, Badrul Islam, et al.
Journal of the Peripheral Nervous System : JPNS|March 14, 2020
Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: Experience beyond the clinical trialsJordi Bruna, Andreas A Argyriou, Garifallia G Anastopoulou, et al.
Journal of the Peripheral Nervous System : JPNS|September 6, 2019
Liability of the voltage-gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin-induced peripheral neurotoxicityAndreas A Argyriou, Anna G Antonacopoulou, Paola Alberti, et al.
Ejhaem|July 18, 2022
Liquid biopsy for disease monitoring after anti-CD19 chimeric antigen receptor T cell in diffuse large B-cell lymphomaClara Maluquer, Beatriz Bellosillo, Alberto Mussetti, et al.
Journal of Clinical Medicine|January 8, 2023
Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case SeriesCarla Marco, Marta Simó, Montse Alemany, et al.
Cancer Chemotherapy and Pharmacology|October 31, 2012
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancerMarta Lucchetta, Sara Lonardi, Francesca Bergamo, et al.
Neurology|May 5, 2026
Sarcopenia in Patients With Cancer and Its Association With Chemotherapy-Induced Peripheral NeurotoxicityRoser Velasco, Sarah Besora, Marta Bellver, et al.
Pageof 6